2013
DOI: 10.1007/s10495-013-0847-1
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-κB

Abstract: Anoikis-resistance of tumor cells is critical for anchorage-independent growth and metastasis. The inflammatory-response transcription factor NF-κB contributes to anoikis-resistance and tumor progression through mechanisms that are understood incompletely. Deleted in Breast Cancer-1 protein (KIAA1967) is over-expressed in several tumor types, and correlates with a poorer prognosis in some cases. We report here that DBC1 suppressed anoikis in normal epithelial and breast cancer cell lines. DBC1 interacted with … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
45
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(48 citation statements)
references
References 49 publications
(60 reference statements)
2
45
0
Order By: Relevance
“…We next examined the nuclear translocation of NF-κB p65, and NF-κB luciferase reporter activity ( Figure 9A). In addition, the protein levels of NF-κB target genes, such as matrix metallopeptidase 9 (MMP9) and cellular FLICE-inhibitory protein (c-FLIP), which are involved in cancer cell invasion and anoikis resistance (29)(30)(31), were increased following IRX1 overexpression. In contrast, IRX1 knockdown in ZOSM and 143B cells significantly decreased NF-κB p65 nuclear translocation, NF-κB-luciferase reporter activity, and expression of MMP9 and c-FLIP ( Figure 9A).…”
Section: Nf-κb Pathway Activation Is Involved In Irx1/cxcl14-induced mentioning
confidence: 99%
“…We next examined the nuclear translocation of NF-κB p65, and NF-κB luciferase reporter activity ( Figure 9A). In addition, the protein levels of NF-κB target genes, such as matrix metallopeptidase 9 (MMP9) and cellular FLICE-inhibitory protein (c-FLIP), which are involved in cancer cell invasion and anoikis resistance (29)(30)(31), were increased following IRX1 overexpression. In contrast, IRX1 knockdown in ZOSM and 143B cells significantly decreased NF-κB p65 nuclear translocation, NF-κB-luciferase reporter activity, and expression of MMP9 and c-FLIP ( Figure 9A).…”
Section: Nf-κb Pathway Activation Is Involved In Irx1/cxcl14-induced mentioning
confidence: 99%
“…To acquire a metastatic potential, CTCs must develop resistance to anoikis [1113]. The adaptive processes that help CTCs evade anoikis include EMT [14,15], metabolic changes and antioxidant activity [1618], activation of receptor tyrosine kinases [1922], activation of the NF-κB pathway [23,24], activation of YAP/TAZ transcription coactivators [25,26], or increased autophagy [2730]. …”
Section: Introductionmentioning
confidence: 99%
“…DBC1 directly interacted with the catalytic domain of SIRT1, thereby inhibiting SIRT1 activities [24]. Moreover, DBC1 is thought to be one key co-factor for the mediation of the IKK-β-NF-κB signaling pathway [25]. DBC1/SIRT1 complex may act an important role in regulation of aging and inflammatory responses.…”
Section: Resultsmentioning
confidence: 99%
“…It has been well documented that one of the SIRT1 downstream gene, DBC1, is a main negative regulator of SIRT1 [24]. In addition, DBC1 is associated with IKK-β to increase NF-κB transcriptional activities [25]. Calliari et al reported SIRT1 activation mitigates neurodegeneration through DBC1inhibition [48].…”
Section: Discussionmentioning
confidence: 99%